CLINICAL_TRIALS
trial_result
· 2019-12-10
Clinical Trial Update: Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial [Phase 2]
Summary
Phase 2 clinical trial evaluating losartan to reduce inflammation and fibrosis in HIV patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hennepin Healthcare Research Institute | Conditions: Inflammation, Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-10